A citation-based method for searching scientific literature

Jennifer D Brooks, Hermann H Nabi, Irene L Andrulis, Antonis C Antoniou, Jocelyne Chiquette, Philippe Després, Peter Devilee, Michel Dorval, Arnaud Droit, Douglas F Easton, Andrea Eisen, Laurence Eloy, Samantha Fienberg, David Goldgar, Eric Hahnen, Yann Joly, Bartha Maria Knoppers, Aisha Lofters, Jean-Yves Masson, Nicole Mittmann, Jean-Sébastien Paquette, Nora Pashayan, Rita Schmutzler, Tracy Stockley, Sean V Tavtigian, Meghan J Walker, Michael Wolfson, Anna Maria Chiarelli, Jacques Simard. J Pers Med 2021
Times Cited: 19







List of co-cited articles
73 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
70
68


Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
346
42

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
192
36

What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
David P French, Susan Astley, Adam R Brentnall, Jack Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Gorman, Elaine F Harkness, Fiona Harrison, Michelle Harvie,[...]. BMC Cancer 2020
18
27

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
129
26

Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada.
Cynthia Mbuya Bienge, Nora Pashayan, Jennifer D Brooks, Michel Dorval, Jocelyne Chiquette, Laurence Eloy, Annie Turgeon, Laurence Lambert-Côté, Jean-Sébastien Paquette, Emmanuelle Lévesque,[...]. J Pers Med 2021
10
50

Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
Parichoy Pal Choudhury, Mark N Brook, Amber N Hurson, Andrew Lee, Charlotta V Mulder, Penny Coulson, Minouk J Schoemaker, Michael E Jones, Anthony J Swerdlow, Nilanjan Chatterjee,[...]. Breast Cancer Res 2021
16
25

Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders' views on a low-risk breast screening pathway.
Lorna McWilliams, Victoria G Woof, Louise S Donnelly, Anthony Howell, D Gareth Evans, David P French. BMC Cancer 2020
12
25

Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.
Jolyn Hersch, Alexandra Barratt, Jesse Jansen, Les Irwig, Kevin McGeechan, Gemma Jacklyn, Hazel Thornton, Haryana Dhillon, Nehmat Houssami, Kirsten McCaffery. Lancet 2015
181
15

European polygenic risk score for prediction of breast cancer shows similar performance in Asian women.
Weang-Kee Ho, Min-Min Tan, Nasim Mavaddat, Mei-Chee Tai, Shivaani Mariapun, Jingmei Li, Peh-Joo Ho, Joe Dennis, Jonathan P Tyrer, Manjeet K Bolla,[...]. Nat Commun 2020
36
15

Health professionals' perspectives on breast cancer risk stratification: understanding evaluation of risk versus screening for disease.
Svetlana Puzhko, Justin Gagnon, Jacques Simard, Bartha Maria Knoppers, Sophia Siedlikowski, Gillian Bartlett. Public Health Rev 2019
14
21

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
Yiwey Shieh, Martin Eklund, Lisa Madlensky, Sarah D Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J Van't Veer, Laura J Esserman, Jeffrey A Tice. J Natl Cancer Inst 2017
108
15

Personalized Screening for Breast Cancer: Rationale, Present Practices, and Future Directions.
Tanir M Allweis, Naama Hermann, Rinat Berenstein-Molho, Michal Guindy. Ann Surg Oncol 2021
10
30

CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants.
Tim Carver, Simon Hartley, Andrew Lee, Alex P Cunningham, Stephanie Archer, Chantal Babb de Villiers, Jonathan Roberts, Rod Ruston, Fiona M Walter, Marc Tischkowitz,[...]. Cancer Epidemiol Biomarkers Prev 2021
22
15

Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.
Tatiane Yanes, Mary-Anne Young, Bettina Meiser, Paul A James. Breast Cancer Res 2020
56
15

The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
501
15

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson,[...]. N Engl J Med 2018
972
15


Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.
Linda Rainey, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders, Daniëlle van der Waal. Psychooncology 2019
19
15

Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014
92
15

Breast cancer risk feedback to women in the UK NHS breast screening population.
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
49
15


Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health Data.
Samuel Alarie, Julie Hagan, Gratien Dalpé, Sina Faraji, Cynthia Mbuya-Bienge, Hermann Nabi, Nora Pashayan, Jennifer D Brooks, Michel Dorval, Jocelyne Chiquette,[...]. J Pers Med 2021
3
100

Of Screening, Stratification, and Scores.
Bartha M Knoppers, Alexander Bernier, Palmira Granados Moreno, Nora Pashayan. J Pers Med 2021
6
50

The current status of risk-stratified breast screening.
Ash Kieran Clift, David Dodwell, Simon Lord, Stavros Petrou, Sir Michael Brady, Gary S Collins, Julia Hippisley-Cox. Br J Cancer 2022
6
50

Epigenome-based cancer risk prediction: rationale, opportunities and challenges.
Martin Widschwendter, Allison Jones, Iona Evans, Daniel Reisel, Joakim Dillner, Karin Sundström, Ewout W Steyerberg, Yvonne Vergouwe, Odette Wegwarth, Felix G Rebitschek,[...]. Nat Rev Clin Oncol 2018
75
10


Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis.
Ewan Gray, Anna Donten, Nico Karssemeijer, Carla van Gils, D Gareth Evans, Sue Astley, Katherine Payne. Value Health 2017
27
10

Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Yvonne Wengström, D Gareth Evans, Louise S Donnelly, Mireille J M Broeders. Breast 2018
18
11

Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling?
Susmita Chowdhury, Lidewij Henneman, Tom Dent, Alison Hall, Alice Burton, Paul Pharoah, Nora Pashayan, Hilary Burton. J Pers Med 2015
10
20

The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes.
Nabil Amara, Jolyane Blouin-Bougie, Jalila Jbilou, Norrin Halilem, Jacques Simard, Réjean Landry. Fam Cancer 2016
8
25

Breast Cancer Risk Estimation and Personal Insurance: A Qualitative Study Presenting Perspectives from Canadian Patients and Decision Makers.
Gratien Dalpé, Ida Ngueng Feze, Shahad Salman, Yann Joly, Julie Hagan, Emmanuelle Lévesque, Véronique Dorval, Jolyane Blouin-Bougie, Nabil Amara, Michel Dorval,[...]. Front Genet 2017
10
20

Genetics and Personal Insurance: the Perspectives of Canadian Cancer Genetic Counselors.
Michelle Lane, Ida Ngueng Feze, Yann Joly. J Genet Couns 2015
9
22

Looking Beyond GINA: Policy Approaches to Address Genetic Discrimination.
Yann Joly, Charles Dupras, Miriam Pinkesz, Stacey A Tovino, Mark A Rothstein. Annu Rev Genomics Hum Genet 2020
13
15

Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years.
Anne Andermann, Ingeborg Blancquaert, Sylvie Beauchamp, Véronique Déry. Bull World Health Organ 2008
472
10

Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
Tom Callender, Mark Emberton, Steve Morris, Ros Eeles, Zsofia Kote-Jarai, Paul D P Pharoah, Nora Pashayan. PLoS Med 2019
34
10

Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History.
Jeroen J van den Broek, Clyde B Schechter, Nicolien T van Ravesteyn, A Cecile J W Janssens, Michael C Wolfson, Amy Trentham-Dietz, Jacques Simard, Douglas F Easton, Jeanne S Mandelblatt, Peter Kraft,[...]. J Natl Cancer Inst 2021
12
16


Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
Jacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, Erin Mundt, Hannah C Cox, Krystal Brown, Melissa Aston, Lisa Esterling, Susan Manley, Theodora Ross. JAMA 2018
114
10

Risk stratification, genomic data and the law.
Alison Hall, Thomas Finnegan, Susmita Chowdhury, Tom Dent, Mark Kroese, Hilary Burton. J Community Genet 2018
3
66

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
328
10

A systematic review and quality assessment of individualised breast cancer risk prediction models.
Javier Louro, Margarita Posso, Michele Hilton Boon, Marta Román, Laia Domingo, Xavier Castells, María Sala. Br J Cancer 2019
49
10

The contributions of breast density and common genetic variation to breast cancer risk.
Celine M Vachon, V Shane Pankratz, Christopher G Scott, Lothar Haeberle, Elad Ziv, Matthew R Jensen, Kathleen R Brandt, Dana H Whaley, Janet E Olson, Katharina Heusinger,[...]. J Natl Cancer Inst 2015
122
10


Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
353
10

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
701
10

Risk stratification in breast cancer screening: Cost-effectiveness and harm-benefit ratios for low-risk and high-risk women.
Valérie D V Sankatsing, Nicolien T van Ravesteyn, Eveline A M Heijnsdijk, Mireille J M Broeders, Harry J de Koning. Int J Cancer 2020
9
22


Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies.
Nikolai Mühlberger, Gaby Sroczynski, Artemisa Gogollari, Beate Jahn, Nora Pashayan, Ewout Steyerberg, Martin Widschwendter, Uwe Siebert. Eur J Health Econ 2021
5
40


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.